- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03802435
Different Sessions of Perineural Injection With Dextrose for Carpal Tunnel Syndrome
April 9, 2024 updated by: Yung-Tsan Wu, Tri-Service General Hospital
Comparison of Long-term Effect in Different Sessions of Perineural Injection With Dextrose for Carpal Tunnel Syndrome
Carpal tunnel syndrome (CTS) is the most common peripheral entrapment neuropathy with involving compression of the median nerve in the carpal tunnel.
The technique of perineural injection therapy (PIT) by using 5% dextrose (D5W) is now commonly used for peeling the nerve from surrounding soft tissue (called nerve hydrodissection), which may help antineurogenic inflammation, allow the impulse to pass, and rescue the nerve with ischemic damage.
However, the evidence and reference of PIT and nerve hydrodissection are very seldom until our series researches since 2017.
Moreover, our research revealed PIT with D5W is more beneficial than that of corticosteroid in patients with mild-to-moderate CTS at 4 to 6 months postinjection.
However, the accumulative effect and long-term effect (more than 6 months) of PIT is still unknown.
Hence, we design a randomized, double- blind, controlled trail to assess the long-term effect of ultrasound-guided PIT in patients with CTS.
The aim one is to survey the possible accumulative effect of different sessions of PIT (6 months follow-up) and aim two is to evaluate the long-term effect and safety of PIT (one year follow-up).
Study Overview
Status
Completed
Conditions
Detailed Description
After obtaining written informed consent, patients clinically diagnosed with mild-to-moderate CTS were includes and randomized into three groups.
Group A, patients received two-sessions of ultrasound-guided PIT with 10cc D5W (3 months interval); Group B, patients received one-session of ultrasound-guided PIT with 10cc D5W and 5cc normal saline separately (3 months interval); Group C (control group), patients received two-sessions of ultrasound-guided PIT with nerve hydrodissection with 10cc normal saline.
The primary outcome is Boston Carpal Tunnel Syndrome Questionnaire (BCTQ) and secondary outcomes include visual analog scale (VAS), cross-sectional area (CSA) of the median nerve, nerve conduction velocity of the median nerve, and Global assessment of treatment.
The evaluations were performed pretreatment as well as on the 1st, 3rd, 6th, 9th month and one year after first injection.
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Yung-Tsan Wu, MD
- Phone Number: 17068 +886287923311
- Email: crwu98@gmail.com
Study Locations
-
-
Neihu District
-
Taipei, Neihu District, Taiwan, 886
- Department of Physical Medicine and Rehabilitation, Tri-Service General Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Age between 20-80 year-old.
- Diagnosis was confirmed using an electrophysiological study
Exclusion Criteria:
- Cancer
- Coagulopathy
- Pregnancy
- Inflammation status
- Cervical radiculopathy
- Polyneuropathy, brachial plexopathy
- Thoracic outlet syndrome
- Previously undergone wrist surgery or steroid injection for CTS
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Two-sessions of ultrasound-guided PIT
two-sessions of ultrasound-guided PIT with 10cc 5% dextrose (3 months interval)
|
two-sessions of ultrasound-guided PIT with 10cc D5W (3 months interval)
|
Active Comparator: One-session of ultrasound-guided PIT
one-session of ultrasound-guided PIT with 10cc 5% dextrose and 10cc normal saline separately (3 months interval)
|
One-session of ultrasound-guided PIT with 10cc D5W and 10cc normal saline separately (3 months interval)
|
Placebo Comparator: Two-session of ultrasound-guided nerve hydrodissection
two-sessions of ultrasound-guided PIT with nerve hydrodissection with 10cc normal saline (3 months interval).
|
Two-sessions of ultrasound-guided PIT with nerve hydrodissection with 10cc normal saline (3 months interval).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline of severity of symptoms and functional status on 1st, 3rd, 6th, 9th month and one year after injection
Time Frame: Pre-treatment, 1st, 3rd, 6th, 9th month and one year after injection
|
Boston carpal tunnel syndrome questionnaire (BCTQ) is a frequently used patient-based questionnaire for measurement of CTS which encompasses two components.
In total, 11 questions and 8 items were evaluated to rate the symptom severity scale (SSS) and functional status scale (FSS), respectively.
Both subscales range from 1 to 5 with a higher score indicating a higher degree of disability.
The mean of total SSS and FSS divided with each item score were used for further analysis.
|
Pre-treatment, 1st, 3rd, 6th, 9th month and one year after injection
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline of pain on 1st, 3rd, 6th, 9th month and one year after injection
Time Frame: Pre-treatment, 1st, 3rd, 6th, 9th month and one year after injection
|
Digital pain severity or paresthesia/dysthesia was evaluated using visual analog scale (VAS).
Pain score scale ranged from 0 to 10, with 10 indicating the most severe pain.
|
Pre-treatment, 1st, 3rd, 6th, 9th month and one year after injection
|
Change from baseline of cross-sectional area of the median nerve on 1st, 3rd, 6th, 9th month and one year after injection
Time Frame: Pre-treatment, 1st, 3rd, 6th, 9th month and one year after injection
|
Using the musculoskeletal sonogram to measure the cross-sectional area of the median nerve before treatment and multiple time frame after treatment.
|
Pre-treatment, 1st, 3rd, 6th, 9th month and one year after injection
|
Change from baseline of electrophysiological measurement on 1st, 3rd, 6th, 9th month and one year after injection
Time Frame: Pre-treatment, 1st, 3rd, 6th, 9th month and one year after injection
|
Antidromic sensory nerve conduction velocity of the median nerve before treatment and multiple time frame after treatment.
|
Pre-treatment, 1st, 3rd, 6th, 9th month and one year after injection
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Yung-Tsan Wu, MD, Department of Physical Medicine and Rehabilitation, Tri-Service General Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Wu YT, Chen SR, Li TY, Ho TY, Shen YP, Tsai CK, Chen LC. Nerve hydrodissection for carpal tunnel syndrome: A prospective, randomized, double-blind, controlled trial. Muscle Nerve. 2019 Feb;59(2):174-180. doi: 10.1002/mus.26358. Epub 2018 Dec 4.
- Wu YT, Ke MJ, Ho TY, Li TY, Shen YP, Chen LC. Randomized double-blinded clinical trial of 5% dextrose versus triamcinolone injection for carpal tunnel syndrome patients. Ann Neurol. 2018 Oct;84(4):601-610. doi: 10.1002/ana.25332. Epub 2018 Oct 4.
- Wu YT, Ho TY, Chou YC, Ke MJ, Li TY, Tsai CK, Chen LC. Six-month Efficacy of Perineural Dextrose for Carpal Tunnel Syndrome: A Prospective, Randomized, Double-Blind, Controlled Trial. Mayo Clin Proc. 2017 Aug;92(8):1179-1189. doi: 10.1016/j.mayocp.2017.05.025.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2019
Primary Completion (Actual)
March 31, 2024
Study Completion (Actual)
March 31, 2024
Study Registration Dates
First Submitted
January 9, 2019
First Submitted That Met QC Criteria
January 11, 2019
First Posted (Actual)
January 14, 2019
Study Record Updates
Last Update Posted (Actual)
April 10, 2024
Last Update Submitted That Met QC Criteria
April 9, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Different PIT for CTS
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Carpal Tunnel Syndrome
-
Stanford UniversityMayo Clinic; Brown University; Duke University; Harvard University; University of...CompletedCarpal Tunnel Syndrome | Carpal Tunnel | Carpal Tunnel Syndrome Bilateral | Carpal Tunnel Syndrome Left | Carpal Tunnel Syndrome RightUnited States
-
Issa, Abdulhamid Sayed, M.D.CompletedCarpal Tunnel Syndrome | CTS | Carpal Tunnel Release | Carpal Tunnel Surgery | Carpal Tunnel Transverse ApproachSyrian Arab Republic
-
Ohio State UniversityCompletedBilateral Carpal Tunnel Syndrome (Diagnosis)United States
-
University of Split, School of MedicineCompletedCarpal Tunnel Syndrome BilateralCroatia
-
CMC Ambroise ParéCompletedCarpal Tunnel ReleaseFrance
-
Vanderbilt UniversityOrthopedic Research and Education FoundationCompleted
-
University of PittsburghWithdrawnPain After Carpal Tunnel ReleaseUnited States
-
Centre Hospitalier Saint Joseph Saint Luc de LyonRecruitingCarpal Tunnel Syndrome BilateralFrance
-
Istituto Ortopedico RizzoliCompletedEntrapment Neuropathy, Carpal Tunnel | Compression Neuropathy, Carpal Tunnel | Median Neuropathy, Carpal TunnelItaly
-
David TangRecruitingCarpal Tunnel Syndrome | Splints | Carpal Tunnel | Nerve Compression | Carpal Tunnel Release | Hand Injuries and DisordersCanada
Clinical Trials on two-sessions of ultrasound-guided PIT
-
Association Pédiatrique des Groupes d'Acuueil et...Bicetre Hospital; Hopital Antoine BeclereUnknownNeonatal HyperbilirubinemiaFrance
-
Cairo UniversityAhmed Elgazzar HospitalCompleted
-
Northumbria Healthcare NHS Foundation TrustCompletedGreater Trochanteric Pain SyndromeUnited Kingdom
-
Universitair Ziekenhuis BrusselCompletedCancer | Malnutrition | InfectionBelgium
-
Masarykova Nemocnice v Usti nad Labem, Krajska...CompletedCentral Vein CatheterCzechia
-
Cabinet de Medecine Interne Générale Demetrio PitarchCompletedAtherosclerosis of Artery
-
Uniwersytecki Szpital Kliniczny w OpoluCompleted
-
Assiut UniversityNot yet recruitingPancreas Pseudocyst
-
Seoul National University HospitalWithdrawnChild | Ultrasonography | Intubation ComplicationKorea, Republic of
-
Asian Institute of Gastroenterology, IndiaCompleted